Catalyst
Slingshot members are tracking this event:
Aerie (AERI) to Submit NDA for Roclatan in Lowering Intraocular Pressure (IOP) in Patients with Glaucoma or Ocular Hypertension in Q2 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AERI |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 15, 2018
Occurred Source:
http://investors.aeriepharma.com/news-releases/news-release-details/aerie-pharmaceuticals-submits-new-drug-application-us-food-and-0
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Roclatan, Lowering Intraocular Pressure, Glaucoma, Ocular Hypertension, Nda
